XOOMAR

Quoin Pharmaceuticals (QNRX)

Quoin Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

20K

Short interest

settlement 2026-10-15

1.0

Days to cover

-0.4 days vs prior

34.0%

Short share of volume

2026-11-02

12,812

Fails to deliver

settlement 2026-10-14

Thu 5 Nov

Next earnings

estimated date

$280K

Insider flow, 90 days

4 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in QNRX is 20,231 shares, down 106,061 shares over the last month. Over the last 48 readings it ranged from 4,008 shares (29 August 2025) to 2,678,655 shares (28 February 2025). The latest reading sits at the bottom of that range. At the reported average volume of 48K shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/qnrx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1520,231-69.1%47,9941.00
2026-09-3065,473-48.2%47,4161.38
2026-09-15126,292-76.0%152,5991.00
2026-08-31526,654+373.2%2,777,3451.00
2026-08-14111,299-3.9%25,1364.43
2026-07-31115,830-25.9%10,82110.70
2026-07-15156,280-40.3%39,9703.91
2026-06-30261,876+555.7%1,319,0311.00
2026-06-1539,939-18.4%33,5651.19
2026-05-2948,916-38.8%37,6191.30
2026-05-1579,876-6.6%14,2265.61
2026-04-3085,556+6.3%29,6492.89
2026-04-1580,474-14.8%35,5332.26
2026-03-3194,409+1136.7%351,1301.00
2026-03-137,634-48.0%17,2611.00
2026-02-2714,672-43.3%33,5631.00
2026-02-1325,875-7.0%21,0761.23
2026-01-3027,827+260.2%38,9621.00
2026-01-157,726-74.1%32,1281.00
2025-12-3129,780-26.5%45,7771.00
2025-12-1540,499-42.7%130,1841.00
2025-11-2870,734-45.7%96,9181.00
2025-11-14130,349+475.3%1,831,5681.00
2025-10-3122,657-71.7%106,5111.00
2025-10-1580,105+1423.5%1,437,1931.00
2025-09-305,258+22.2%227,7051.00
2025-09-154,304+7.4%1,7222.50
2025-08-294,008-35.1%2,9581.35
2025-08-156,175-31.4%3,3361.85
2025-07-319,000-1.7%4,8401.86
2025-07-159,152-8.9%3,5492.58
2025-06-3010,043-71.0%10,6221.00
2025-06-1334,696-33.5%13,1242.64
2025-05-3052,182-76.8%42,2861.23
2025-05-15225,364+1075.0%918,0661.00
2025-04-3019,180+53.4%49,9271.00
2025-04-1512,505-92.8%611,4131.00
2025-03-31174,011-80.0%401,2131.00
2025-03-14868,761-67.6%720,5791.21
2025-02-282,678,655+5934.2%19,077,1101.00
2025-02-1444,391-16.0%6,137,1781.00
2025-01-3152,821-87.1%7,104,8131.00
2025-01-15410,402-40.8%479,0551.00
2024-12-31692,967+310.2%2,077,4701.00
2024-12-13168,930+77.5%4,706,2971.00
2024-11-2995,148-65.3%82,0021.16
2024-11-15274,488-42.6%167,9371.63
2024-10-31478,429+2395.5%11,244,2201.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of QNRX volume is 34.0%, down 29.9 points over the last five sessions. Over the last 30 readings it ranged from 15.4% (30 September 2026) to 91.0% (28 October 2026). The latest reading is 15.7 points below the 30-session average of 49.6%, on 6K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-022K6K34.0%462
2026-10-305K9K53.2%721
2026-10-296761K47.2%0
2026-10-282K2K91.0%0
2026-10-2739953075.3%0
2026-10-265K8K63.9%200
2026-10-2329490232.6%0
2026-10-223K8K31.5%0
2026-10-214K5K86.8%0
2026-10-202K4K42.4%0
2026-10-195K7K68.7%0
2026-10-1622K25K89.0%0
2026-10-153K10K29.0%0
2026-10-146K15K36.8%0
2026-10-131K5K26.1%0
2026-10-1211K18K64.2%200
2026-10-096K13K47.7%0
2026-10-083K7K36.9%0
2026-10-075K10K45.4%0
2026-10-0619K23K82.0%2,675
2026-10-053K7K39.0%0
2026-10-023K6K57.7%0
2026-10-013K6K60.0%0
2026-09-306K38K15.4%741
2026-09-2914K36K39.7%505
2026-09-2817K23K72.8%5,073
2026-09-258673K26.1%33
2026-09-242K8K21.0%0
2026-09-232K6K44.6%0
2026-09-221K5K29.5%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in QNRX is 12,812 shares, up 1,099 shares over the last settlement date. Over the last 30 readings it ranged from 41 shares (21 September 2026) to 182,046 shares (31 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-1412,812$4.15$53K
2026-10-1311,713$4.36$51K
2026-10-098,101$4.55$37K
2026-10-0812,984$4.51$59K
2026-10-0711,884$4.72$56K
2026-10-0612,857$4.56$59K
2026-10-055,894$4.47$26K
2026-10-027,350$4.72$35K
2026-10-017,634$4.56$35K
2026-09-304,453$4.88$22K
2026-09-2918,687$5.37$100K
2026-09-28278$6.43$2K
2026-09-25773$6.38$5K
2026-09-241,013$6.75$7K
2026-09-23163$7.01$1K
2026-09-2141$7.06$289
2026-09-18106$7.01$743
2026-09-1514,546$6.88$100K
2026-09-1411,726$6.79$80K
2026-09-1160$6.90$414
2026-09-10549$6.97$4K
2026-09-087,708$7.26$56K
2026-09-046,599$7.87$52K
2026-09-0227,588$6.51$180K
2026-09-0170,683$6.22$440K
2026-08-31182,046$6.12$1.1M
2026-08-27100$5.15$515
2026-08-245,006$5.57$28K
2026-08-21880$4.99$4K
2026-08-1981$4.97$403

Insider trades

SEC Form 4, newest first. JSON

Insiders at QNRX reported 4 open-market buys worth $280K in the last 90 days and no open-market sells. Latest filing: Myers Michael (Chief Executive Officer) on 2026-08-31.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-31Myers MichaelChief Executive OfficerBuy20K$4.88$100K38K
2026-08-31Lawlor Sally BridgetChief Financial OfficerBuy10K$4.88$50K11K
2026-08-31Culverwell Anthony JamesDirectorBuy6K$4.88$30K40K
2026-08-31Carter Denise P.Chief Operating OfficerBuy20K$4.88$100K38K
2026-08-27LANGER DENNISDirectorGrant35K$5.15$178K56K
2026-08-27Culverwell Anthony JamesDirectorGrant31K$5.15$161K34K
2025-10-14LANGER DENNISDirectorBuy15K$8.49$129K15K
2024-12-23Culverwell Anthony JamesDirectorBuy100K$0.45$45K100K
2024-12-23Dunn GordonChief Financial OfficerBuy122K$0.45$55K151K
2024-12-23Myers MichaelChief Executive OfficerBuy556K$0.45$250K603K
2024-12-23Carter Denise P.Chief Operating OfficerBuy556K$0.45$250K603K
2024-09-10Dunn GordonChief Financial OfficerBuy10K$0.71$7K29K
2024-09-10Dunn GordonChief Financial OfficerBuy10K$0.91$9K19K
2024-09-09Dunn GordonChief Financial OfficerBuy4K$0.78$3K5K
2024-09-09Dunn GordonChief Financial OfficerBuy856$0.80$685856
2024-09-09Dunn GordonChief Financial OfficerBuy4K$0.80$3K9K
2024-09-04Myers MichaelChief Executive OfficerBuy8K$0.75$6K24K
2024-09-04Myers MichaelChief Executive OfficerBuy24K$0.80$19K47K
2024-09-04Myers MichaelChief Executive OfficerBuy5K$0.66$4K15K
2024-09-04Carter Denise P.Chief Operating OfficerBuy23K$0.80$18K47K
2024-09-04Carter Denise P.Chief Operating OfficerBuy9K$0.75$7K24K
2024-09-03Myers MichaelChief Executive OfficerBuy800$0.62$49610K
2024-09-03Carter Denise P.Chief Operating OfficerBuy2K$0.63$1K11K
2024-09-03Carter Denise P.Chief Operating OfficerBuy4K$0.66$3K15K
2024-06-07LANGER DENNISDirectorSell297$0.73$21753

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

10 holders report 5% or more of QNRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Stonepine Capital, L.P. at 10.0% of the class (7,594,166 shares), filed 2026-05-15 for an event on 2026-03-31.

FiledFormHolderSharesOf classEvent
2026-10-0713G/Ano. 2Ikarian Capital, LLCinvestment adviser212K4.4%2026-09-30
2026-10-0713G/Ano. 2Neil Shahrestaniparent holding company, individual212K4.4%2026-09-30
2026-06-0213GIsrael A. Englanderindividual3.9M5.5%2026-05-26
2026-06-0213GMillennium Group Management LLCother entity3.9M5.5%2026-05-26
2026-06-0213GMillennium Management LLCother entity3.9M5.5%2026-05-26
2026-06-0213GIntegrated Core Strategies (US) LLCother entity3.9M5.5%2026-05-26
2026-05-1513G/Ano. 1Daniel Schneebergerparent holding company, individual103K4.9%2026-03-31
2026-05-1513G/Ano. 1ADAR1 Capital Management, LLCinvestment adviser, other entity103K4.9%2026-03-31
2026-05-1513G/Ano. 1ADAR1 Capital Management GP, LLCother entity103K4.9%2026-03-31
2026-05-1513G/Ano. 2Stonepine Capital, L.P.partnership7.6M10.0%2026-03-31
2026-05-1513G/Ano. 2Jon M. Plexicoparent holding company, individual7.6M10.0%2026-03-31
2026-05-1513G/Ano. 2Stonepine GP, LLCother entity7.6M10.0%2026-03-31
2026-05-1513G/Ano. 2Stonepine Capital Management, LLCinvestment adviser, other entity7.6M10.0%2026-03-31
2026-05-1513G/Ano. 1Woodline Partners LPinvestment adviser, partnership2.8M4.4%2026-03-31
2026-04-2913G/Ano. 1Aberdeen Group plcparent holding company75K4.2%2026-04-01
2026-04-2913G/Ano. 1abrdn Inc.corporation, investment adviser75K4.2%2026-04-01
2025-12-1113GResolute Capital Asset Partners LLCinvestment adviser50K8.5%2025-10-10
2025-12-1113GResolute Capital Asset Partners Fund I LPother entity, partnership50K8.5%2025-10-10

13F holders

Tracked managers holding QNRX at their latest 13F. JSON

1 of the 30 tracked managers held QNRX at their latest 13F, $544K in total at quarter-end prices. Millennium Management is the largest at $544K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-30112K$544K0.00%+36K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Quoin Pharmaceuticals in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Quoin Pharmaceuticals (QNRX), SEC CIK 1671502, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-07.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-31.JSON and CSV
Company record
EDGAR filing index for CIK 1671502Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of QNRX is sold short?
20,231 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is QNRX's daily short volume?
On 2026-11-02, 2,200 of the 6,474 QNRX shares reported to FINRA were sold short, 34.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does QNRX have fails to deliver?
The SEC's latest file shows 12,812 QNRX shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are QNRX insiders buying or selling?
Insiders at QNRX reported 4 open-market buys worth $280K in the last 90 days and no open-market sells. Latest filing: Myers Michael (Chief Executive Officer) on 2026-08-31.
Who owns 5% or more of QNRX?
10 holders report 5% or more of QNRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Stonepine Capital, L.P. at 10.0% of the class (7,594,166 shares), filed 2026-05-15 for an event on 2026-03-31.
Which tracked 13F managers own QNRX?
1 of the 30 tracked 13F managers held QNRX shares at their latest filing, $544K in all. The largest: Izzy Englander's Millennium Management (112K shares, $544K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.